Abstract:Background: Streptomyces chattanoogensis L10 is the industrial producer of natamycin and has been proved a highly efficient host for diverse natural products. It has an enormous potential to be developed as a versatile cell factory for production of heterologous secondary metabolites. Here we developed a genome-reduced industrial Streptomyces chassis by rational 'design-build-test' pipeline. Results: To identify candidate large non-essential genomic regions accurately and design large deletion rationally, we performed genome analyses of S. chattanoogensis L10 by multiple computational approaches, optimized Cre/loxP recombination system for high-efficient large deletion and constructed a series of universal suicide plasmids for rapid loxP or loxP mutant sites inserting into genome. Subsequently, two genome-streamlined mutants, designated S. chattanoogensis L320 and L321, were rationally constructed by depletion of 1.3 Mb and 0.7 Mb non-essential genomic regions, respectively. Furthermore, several biological performances like growth cycle, secondary metabolite profile, hyphae morphological engineering, intracellular energy (ATP) and reducing power (NADPH/NADP(+)) levels, transformation efficiency, genetic stability, productivity of heterologous proteins and secondary metabolite were systematically evaluated. Finally, our results revealed that L321 could serve as an efficient chassis for the production of polyketides. Conclusions: Here we developed the combined strategy of multiple computational approaches and site-specific recombination system to rationally construct genome-reduced Streptomyces hosts with high efficiency. Moreover, a genome-reduced industrial Streptomyces chassis S. chattanoogensis L321 was rationally constructed by the strategy, and the chassis exhibited several emergent and excellent performances for heterologous expression of secondary metabolite. The strategy could be widely applied in other Streptomyces to generate miscellaneous and versatile chassis with minimized genome. These chassis can not only serve as cell factories for high-efficient production of valuable polyketides, but also will provide great support for the upgrade of microbial pharmaceutical industry and drug discovery.

Improvement of Pristinamycin-Producing Streptomyces Pristinaespiralis by Rational Screening

Generation of high rapamycin producing strain via rational metabolic pathway-based mutagenesis and further titer improvement with fed-batch bioprocess optimization.

Screening of High Pristinamycin-Producing Strain by Combined Mutation

Glycine Feeding Improves Pristinamycin Production During Fermentation Including Resin for in Situ Separation.

Improved production of pristinamycin coupled with an adsorbent resin in fermentation by Streptomyces pristinaespiralis

Medium Optimization Based on Statistical Methodologies for Pristinamycins Production by Streptomyces Pristinaespiralis

Identification of Two Novel Regulatory Genes Involved in Pristinamycin Biosynthesis and Elucidation of the Mechanism for AtrA-p-mediated Regulation in Streptomyces Pristinaespiralis

Strain Improvement of Streptomyces Roseosporus for Daptomycin Production by Rational Screening of He–Ne Laser and NTG Induced Mutants and Kinetic Modeling

Rational screening for high production tacrolimus-producing strain

60Co Γ-Irradiation MUTATION INDUCTION FOR SCREENING OF AVILAMYCIN STRAINS WITH HIGH PRODUCTIVITY AND ITS CULTURE MEDIUM OPTIMIZATION

Improved Neomycin Sulfate Potency in Streptomyces fradiae Using Atmospheric and Room Temperature Plasma (ARTP) Mutagenesis and Fermentation Medium Optimization

Protoplast Preparation of Trichoderma Taxi ZJUF0986 and Screening of Resistant Mutants

Rational Construction of Genome-Reduced and High-Efficient Industrial Streptomyces Chassis Based on Multiple Comparative Genomic Approaches.

Daptomycin production enhancement by ARTP mutagenesis and fermentation optimization in Streptomyces roseosporus

Process Modeling of in Situ-Adsorption of Pristinamycin in Fermentation by Streptomyces Pristinaespiralis

Superior production of heavy pamamycin derivatives using a bkdR deletion mutant of Streptomyces albus J1074/R2

Screening of high proline yield mutants by rapid mutation using atmospheric and room temperature plasmas

Avilamycin production enhancement by mutagenesis and fermentation optimization in Streptomyces viridochromogenes

Improvement of uridine production of Bacillus subtilis by atmospheric and room temperature plasma mutagenesis and high-throughput screening

Genomic Variability among High Pristinamycin-Producing Recombinants of Streptomyces Pristinaespiralis Revealed by Amplified Fragment Length Polymorphism

Enhancement of doxorubicin production in Streptomyces peucetius by genetic engineering and process optimization